FDA-APPROVED FOR A SPECIFIC USE
What is Formula T (Tirzepatide)?
Tirzepatide is a dual GLP-1/GIP receptor agonist. It is FDA-approved under specific brand names for type 2 diabetes management and chronic weight management, and is one of the most studied compounds in its class.
Areas of Research Interest
- Dual-receptor agonism and glucose regulation studies
- Body weight management clinical research
- Cardiometabolic outcomes research
- Long-term safety and tolerability studies
Regulatory Status
Tirzepatide is FDA-approved under specific brand names for type 2 diabetes and chronic weight management. Uses outside these approved indications, or non-branded/compounded versions, are not FDA-approved.
Educational information only. This content is not intended to diagnose, treat, cure, or prevent any disease, and does not provide guidance on personal use, dosing, or administration. Consult qualified professionals and current regulatory sources for guidance specific to your situation.